Jean Marie Cuillerot
About Jean Marie Cuillerot
Jean-Marie Cuillerot Chief Medical Officer
Jean-Marie Cuillerot is a seasoned medical professional currently serving as Chief Medical Officer. He brings a wealth of experience in clinical development and immuno-oncology, having previously held significant roles in multiple renowned organizations. His leadership in clinical development and innovative approaches to medical treatments have greatly influenced the field.
Jean-Marie Cuillerot at Dragonfly Therapeutics
Jean-Marie Cuillerot previously served as the Chief Medical Officer at Dragonfly Therapeutics. In this role, he focused on advancing therapeutic programs and steering clinical development efforts. His tenure at Dragonfly Therapeutics reinforced his expertise in immuno-oncology and clinical research.
Jean-Marie Cuillerot at Agenus
Jean-Marie Cuillerot also held the position of Chief Medical Officer at Agenus. Here, he played a vital role in the strategic development and execution of clinical trials, contributing to the advancement of therapeutic candidates in immuno-oncology. His work at Agenus further solidified his reputation as a leader in clinical development.
Jean-Marie Cuillerot at EMD Serono
Jean-Marie Cuillerot's tenure as the global head of clinical development in immuno-oncology and vice president of clinical immunotherapy and immuno-oncology at EMD Serono was marked by significant achievements. Notably, he led the clinical development of avelumab from pre-IND through global approvals, earning the Merck CEO award for his rapid and effective leadership.
Jean-Marie Cuillerot Education Background
Jean-Marie Cuillerot holds a comprehensive educational background from the University Louis Pasteur (Strasbourg, France). He earned a B.S. in biochemistry, an M.Sc. in cellular and molecular biology, and an M.D. from this institution. This educational foundation has been fundamental to his extensive contributions in the field of medical research and clinical development.